Duran Group has entered an agreement to acquire Kimble Chase Life Sciences & Research Products from Gerresheimer for a purchase consideration of $131m.

The acquisition is expected to be completed by November and will enable the acquirer to expand its presence in life sciences and research field, as well as services in the US.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Catalent subsidiary Catalent Pharma Solutions plans to expand its drug development services and spray-drying technology through the acquisition of Pharmatek laboratories.

The acquirer is an advanced drug delivery technologies and development solutions provider, whereas the target is a drug development and clinical manufacturing company.

 

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact